Treace Medical Concepts, Inc. TMCI Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s amortization expense related to capitalized debt issuance costs?
- Treace Medical Concepts, Inc. (TMCI) reported amortization expense related to capitalized debt issuance costs of $262K in Q1 2026.
- How has Treace Medical Concepts, Inc.'s amortization expense related to capitalized debt issuance costs changed year-over-year?
- Treace Medical Concepts, Inc.'s amortization expense related to capitalized debt issuance costs increased by 254.1% year-over-year, from $74K to $262K.
- What is the long-term trend for Treace Medical Concepts, Inc.'s amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s amortization expense related to capitalized debt issuance costs has grown at a 13.5% compound annual growth rate (CAGR), from $176K to $292K.